Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment

NI Agalakova - International Journal of Molecular Sciences, 2024 - mdpi.com
Chloroquine (CQ) and its derivate hydroxychloroquine (HCQ), the compounds with
recognized ability to suppress autophagy, have been tested in experimental works and in …

A green bioanalytical spectrofluorimetric approach for estimation of Avapritinib anti-tumor drug; application to quality control and clinical studies

BI Salman, RE Saraya, YF Hassan, AI Hassan… - Bioanalysis, 2025 - Taylor & Francis
ABSTRACT Aims Gastrointestinal stromal tumors (GISTs) account for about 80% of the
mesenchymal tumors of the GI tract. About 5000–6000 patients are diagnosed in the United …

Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers

B Biersack, L Tahtamouni, M Höpfner - Receptors, 2024 - mdpi.com
The development of potent BRAF inhibitors has revolutionized the treatment of BRAF mutant
cancers, in particular, melanomas. However, BRAF mutant cancers of other entities, eg …

Comment on Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. Cancers 2023, 15, 4081

A Chen, X Zhang - Cancers, 2023 - pmc.ncbi.nlm.nih.gov
We carefully read the article written by Golcic et al.“Evaluation of Systemic Treatment
Options for Gastrointestinal Stromal Tumours”[1]. The authors included the dose escalation …

Reply to Chen, A.; Zhang, X. Comment on “Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. Cancers 2023, 15, 4081”

M Golčić, RL Jones, P Huang, A Napolitano - Cancers, 2023 - pmc.ncbi.nlm.nih.gov
We appreciate the comment made by Chen et al. on our manuscript evaluating the systemic
treatment options for gastrointestinal stromal tumours (GIST)[1]. Their comment serves as a …